• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Dr Joshua Benner Discusses the Importance of PQA's New Opioid Measures

Video

The new opioid quality measures by the Pharmacy Quality Alliance are a first step forward for improving use of prescription opioids.

At its 10th Annual Meeting in Arlington, Virginia, the Pharmacy Quality Alliance announced its new opioid quality measures, and RxAnte helped in the development and testing of these measures, explained Joshua Benner, PharmD, ScD, executive vice president of strategy and corporate development at Millennium Health and former president and chief executive officer of RxAnte.

The measures are just a first step, but what is important is that they develop a common definition of what appropriate use of prescription opioids actually is, Dr Benner said.

"As we develop experience using those measures in practice, we'll learn more about how they should be refined over time," he said.

Related Videos
Pat Van Burkleo
Jeff Stark, MD, vice president, head of medical immunology, UCB
Robert Groves, MD
Screenshot of Raajit Rampal, MD, PhD
 Laura Ferris, MD, PhD, professor of dermatology, University of Pittsburgh
Dr Padma Sripada, Columbia Internal Medicine
Screenshot of Jennifer Vaughn, MD, in a Zoom video interview
dr amy paller
Shawn Kwatra, MD, dermatologist, John Hopkins University
Related Content
© 2024 MJH Life Sciences
AJMC®
All rights reserved.